Close Menu

NEW YORK (GenomeWeb) – The US Patent and Trademark Office has denied an attempt by Foundation Medicine to invalidate a patent held by Guardant Health.

In a decision issued June 5, the Patent Trial and Appeal Board denied Foundation Medicine's request to institute Inter Partes review for US Patent No. 9,598,731.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.